Clinical information
Diagnostic Utility:
This is the most important erythrocyte blood group and its determination is useful in:
- Blood transfusion
- Monitoring pregnant women
- Transplantation of progenitor cells, solid organs, and tissues
Method:
Hemagglutination. The blood group and serological group are determined.
Reference Values
Possible results are: A Positive, A Negative, O Positive, O Negative, B Positive, B Negative, AB Positive, AB Negative.
In some cases, it is not possible to obtain any of these results due to a discrepancy between the blood group and the serological group.
Diagnostic Algorithm:
In case of discrepancy between the blood group and the serological group, and in order to obtain an unequivocal result, the cause must be investigated using test 0017: ABO Group Discrepancy Study.
Code | Test Name | Can it be requested separately? | Is it always done? |
---|---|---|---|
0017 | ABO Group Discrepancy Study | Yes (*) | No |
(*) When the requesting centre has already detected the serological discrepancy, it can directly request the performance of this test.
Response Time:
1 day. Serological discrepancy studies may require more time.
Specimen information
Sample: Whole blood
Tube: EDTA K3 10 ml tube
Minimum necessary volume: 3 ml
Stability:
- At room temperature: 4 days
- In the refrigerator: 10 days
Transport instructions: Preferably at room temperature
Reason for rejection: Highly hemolyzed sample
Administrative information
BST Code: 0009
Test Description: ABO/Rh (D) Group
Synonyms: Blood group, ABO and Rh Group
Section: Immunohematology
BST Rate: Check the updated rates here.
Profiles:
Test 0009 ABO/Rh (D) Group can be requested individually. It is also performed within the following profiles:
Profile | Included Tests |
---|---|
Immunohematological control profile for pregnant women |
0009 ABO/Rh (D) Group 0010 Irregular Antibody Screening |
Fetomaternal incompatibility study (mother) Haemolytic disease of the newborn (mother) |
0009 ABO/Rh (D) Group 0010 Irregular Antibody Screening 9994 Incompatibility Conclusion |
Fetomaternal incompatibility study (child) |
0009 ABO/Rh (D) Group 0012 Direct Antiglobulin Test 0014 Erythrocyte Antibody Elution 9994 Incompatibility Conclusion |
References
AABB Technical Manual. 19th edition. Editat per MK Fung, AF Eder, SL Spitalnik, CM Westhoff: AABB 2017